Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions
Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance....
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 76; no. 1; pp. 4 - 6 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
01.01.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0008-5472 1538-7445 |
DOI | 10.1158/0008-5472.CAN-15-3024 |
Cover
Loading…
Abstract | Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published. Cancer Res; 76(1); 4–6. ©2016 AACR.
See related article by Heppner, Cancer Res 1984;44:2259-65. |
---|---|
AbstractList | Heterogeneity is commonplace in all cancer types and at several levels--intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published. Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published. Cancer Res; 76(1); 4–6. ©2016 AACR. See related article by Heppner, Cancer Res 1984;44:2259-65. |
Author | Welch, Danny R. |
Author_xml | – sequence: 1 givenname: Danny R. surname: Welch fullname: Welch, Danny R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26729788$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb1OwzAUhS1UREvhEUAeWQJ2YudHTFUEtFIFDGW2EtstRokdbGdg60MwwOv1SXAEZWBg8r1X37F9zzkGI220BOAMo0uMaX6FEMojSrL4spzdR5hGCYrJAZhgmuRRRggdgckvMwbHzr2ElmJEj8A4TrO4yPJ8AqpV3xoL59JLazZSS-Xfdtv3GdxtP0qjvWw7Yyv7BkPDZed32094a3otpIBGw7ly3ljFqwYutFObZ-9gpQV8tFIo7pXR7gQcrqvGydOfcwqebm9W5TxaPtwtytky4iSOfRSnCHFUICxphkVS1Ihm6xSHn4qEFBQlSYpDgUVOa1SLuK4LXmNekJyu0zBMpuDi-97OmtdeOs9a5bhsmkpL0zuGM0pQkZAMBfT8B-3rVgrWWdWGHdnelgBcfwPcGuesXDOufDWs422lGoYRG0Jgg8FsMJiFEBimbAghqOkf9f6B_3Vfu1mMcA |
CitedBy_id | crossref_primary_10_1002_pmic_201500424 crossref_primary_10_1158_0008_5472_CAN_16_0152 crossref_primary_10_1016_j_ctrv_2024_102843 crossref_primary_10_1016_j_phymed_2021_153830 crossref_primary_10_1002_admt_202301306 crossref_primary_10_1007_s10549_021_06472_5 crossref_primary_10_1158_1541_7786_MCR_21_0986 crossref_primary_10_1021_jacs_8b08931 crossref_primary_10_1016_j_biopha_2018_06_149 crossref_primary_10_1158_0008_5472_CAN_19_0458 crossref_primary_10_1186_s12885_020_07604_8 crossref_primary_10_31793_1680_1466_2020_25_3_227 crossref_primary_10_1039_C8NA00089A crossref_primary_10_1186_s12935_024_03538_4 crossref_primary_10_3390_jpm10040188 crossref_primary_10_1016_j_bioadv_2023_213301 crossref_primary_10_24018_ejmed_2020_2_5_482 crossref_primary_10_2967_jnmt_121_263534 crossref_primary_10_1016_j_csbj_2019_11_009 crossref_primary_10_1017_erm_2021_5 crossref_primary_10_1016_j_bbcan_2016_11_005 crossref_primary_10_1007_s10555_022_10077_9 crossref_primary_10_3390_cancers11101574 crossref_primary_10_1038_s41416_020_01125_8 crossref_primary_10_1200_EDBK_158808 crossref_primary_10_3389_fonc_2021_762023 crossref_primary_10_1016_j_semcdb_2016_08_025 crossref_primary_10_1136_jcp_2024_209597 crossref_primary_10_3389_fonc_2022_963884 crossref_primary_10_3390_cancers12123636 crossref_primary_10_3390_cancers13236100 crossref_primary_10_1098_rsif_2017_0490 crossref_primary_10_1158_0008_5472_CAN_16_0585 crossref_primary_10_3390_ijms22105246 crossref_primary_10_1634_theoncologist_2019_0650 crossref_primary_10_1039_D1AN00751C crossref_primary_10_1101_cshperspect_a028332 crossref_primary_10_3390_ijerph20032392 crossref_primary_10_1038_s41598_023_35313_2 crossref_primary_10_1039_D2SM00015F crossref_primary_10_1021_acsami_3c17673 crossref_primary_10_1088_1478_3975_ab1a09 crossref_primary_10_1364_BOE_7_004007 crossref_primary_10_1038_s41556_018_0236_7 crossref_primary_10_1038_s41598_017_12557_3 crossref_primary_10_1186_s40364_024_00654_1 crossref_primary_10_1007_s13277_016_5161_4 crossref_primary_10_1158_0008_5472_CAN_17_0790 crossref_primary_10_1186_s12957_022_02615_0 crossref_primary_10_3390_cells13010003 crossref_primary_10_1097_JP9_0000000000000014 crossref_primary_10_1186_s12885_020_06807_3 crossref_primary_10_3390_cancers14030633 crossref_primary_10_1016_j_trecan_2020_02_016 crossref_primary_10_1021_envhealth_3c00132 crossref_primary_10_1002_adfm_201807553 crossref_primary_10_1021_acs_bioconjchem_0c00119 crossref_primary_10_1007_s00418_023_02258_6 crossref_primary_10_1016_j_urolonc_2018_05_008 crossref_primary_10_3389_fonc_2019_00455 crossref_primary_10_1038_s41379_022_01012_y crossref_primary_10_1007_s10555_023_10111_4 crossref_primary_10_1016_j_prp_2023_154837 crossref_primary_10_3748_wjg_v24_i24_2567 crossref_primary_10_1007_s00216_019_01694_5 crossref_primary_10_1186_s13059_019_1830_0 crossref_primary_10_1016_j_trecan_2020_08_004 crossref_primary_10_1186_s41747_017_0006_5 crossref_primary_10_1002_path_5036 crossref_primary_10_1080_14737140_2019_1552138 crossref_primary_10_1016_j_heliyon_2024_e25570 crossref_primary_10_1042_BSR20181271 crossref_primary_10_1016_S1470_2045_18_30332_2 crossref_primary_10_1038_bjc_2017_5 crossref_primary_10_3390_cancers16050951 |
Cites_doi | 10.1007/s10555-013-9435-7 10.1016/j.ccr.2012.03.003 10.1038/nature12624 10.1038/nature12628 10.1158/0008-5472.CAN-12-3678 10.1158/0008-5472.CAN-12-2217 10.1126/science.1256930 10.1038/onc.2014.475 10.1158/0008-5472.CAN-15-0074 10.1038/nrc3063 10.1126/science.1254257 10.1007/s10555-013-9426-8 10.1038/nrc3206 10.1038/nrc905 10.1158/0008-5472.CAN-07-5835 10.1007/BF01786761 10.1054/bjoc.2001.1743 10.1038/nrc3726 10.1002/ijc.2910450532 10.1007/s10585-008-9182-2 10.1038/nature13952 |
ContentType | Journal Article |
Copyright | 2016 American Association for Cancer Research. |
Copyright_xml | – notice: 2016 American Association for Cancer Research. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1158/0008-5472.CAN-15-3024 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 6 |
ExternalDocumentID | 26729788 10_1158_0008_5472_CAN_15_3024 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA087728 – fundername: NCI NIH HHS grantid: P30 CA168524 – fundername: NCI NIH HHS grantid: R01 CA134981 |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 53G 5GY 5RE 5VS 6J9 AAFWJ AAJMC AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AETEA AFHIN AFOSN AFRAH AFUMD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c422t-2600c0901e571d39b057f61267d3495033613491d85b0bd2bb9cb1c9485f6d853 |
ISSN | 0008-5472 |
IngestDate | Thu Jul 10 23:09:21 EDT 2025 Thu Apr 03 06:50:31 EDT 2025 Tue Jul 01 01:40:51 EDT 2025 Thu Apr 24 23:01:13 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2016 American Association for Cancer Research. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c422t-2600c0901e571d39b057f61267d3495033613491d85b0bd2bb9cb1c9485f6d853 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://doi.org/10.1158/0008-5472.CAN-15-3024 |
PMID | 26729788 |
PQID | 1754093470 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_1754093470 pubmed_primary_26729788 crossref_citationtrail_10_1158_0008_5472_CAN_15_3024 crossref_primary_10_1158_0008_5472_CAN_15_3024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-01-01 2016-Jan-01 20160101 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – month: 01 year: 2016 text: 2016-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationTitleAlternate | Cancer Res |
PublicationYear | 2016 |
References | Gilkes (2022061704582044300_bib22) 2014; 14 Fox (2022061704582044300_bib12) 2013; 32 Meacham (2022061704582044300_bib7) 2013; 501 Klein (2022061704582044300_bib6) 2013; 501 De Jaeger (2022061704582044300_bib21) 2001; 84 Patel (2022061704582044300_bib4) 2014; 344 Lunt (2022061704582044300_bib20) 2009; 26 Welch (2022061704582044300_bib3) 1989 Skibinski (2022061704582044300_bib8) 2015; 34 Loeb (2022061704582044300_bib13) 2011; 11 Kerbel (2022061704582044300_bib23) 2002; 2 Waghorne (2022061704582044300_bib19) 1988; 48 Loeb (2022061704582044300_bib14) 2008; 68 Welch (2022061704582044300_bib2) 1985; 3 Huang (2022061704582044300_bib9) 2013; 32 Hunter (2022061704582044300_bib16) 2012; 12 Valent (2022061704582044300_bib10) 2013; 73 Feeley (2022061704582044300_bib15) 2015; 75 Heppner (2022061704582044300_bib1) 1984; 44 Swanton (2022061704582044300_bib17) 2012; 72 Price (2022061704582044300_bib18) 1990; 45 Eirew (2022061704582044300_bib24) 2015; 518 Zhang (2022061704582044300_bib5) 2014; 346 Magee (2022061704582044300_bib11) 2012; 21 3167857 - Cancer Res. 1988 Nov 1;48(21):6109-14 26471915 - Cancer Res. 2015 Oct 15;75(20):4429-36 24925914 - Science. 2014 Jun 20;344(6190):1396-401 11336482 - Br J Cancer. 2001 May 4;84(9):1280-5 22439924 - Cancer Cell. 2012 Mar 20;21(3):283-96 24048069 - Nature. 2013 Sep 19;501(7467):365-72 12360276 - Nat Rev Cancer. 2002 Oct;2(10):727-39 21593786 - Nat Rev Cancer. 2011 Jun;11(6):450-7 24827502 - Nat Rev Cancer. 2014 Jun;14(6):430-9 25703331 - Oncogene. 2015 Oct 16;34(42):5309-16 23002210 - Cancer Res. 2012 Oct 1;72(19):4875-82 18543068 - Clin Exp Metastasis. 2009;26(1):19-34 25301631 - Science. 2014 Oct 10;346(6206):256-9 22257951 - Nat Rev Cancer. 2012 Feb;12(2):144-9 2159442 - Int J Cancer. 1990 May 15;45(5):968-71 3902300 - Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88 23592419 - Cancer Metastasis Rev. 2013 Dec;32(3-4):353-61 23640024 - Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48 18483233 - Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557 25470049 - Nature. 2015 Feb 19;518(7539):422-6 6372991 - Cancer Res. 1984 Jun;44(6):2259-65 23345162 - Cancer Res. 2013 Feb 1;73(3):1037-45 24048065 - Nature. 2013 Sep 19;501(7467):328-37 |
References_xml | – volume: 32 start-page: 423 year: 2013 ident: 2022061704582044300_bib9 article-title: Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-013-9435-7 – volume: 21 start-page: 283 year: 2012 ident: 2022061704582044300_bib11 article-title: Cancer stem cells: impact, heterogeneity, and uncertainty publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.03.003 – volume: 501 start-page: 328 year: 2013 ident: 2022061704582044300_bib7 article-title: Tumour heterogeneity and cancer cell plasticity publication-title: Nature doi: 10.1038/nature12624 – volume: 501 start-page: 365 year: 2013 ident: 2022061704582044300_bib6 article-title: Selection and adaptation during metastatic cancer progression publication-title: Nature doi: 10.1038/nature12628 – volume: 73 start-page: 1037 year: 2013 ident: 2022061704582044300_bib10 article-title: Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-3678 – volume: 72 start-page: 4875 year: 2012 ident: 2022061704582044300_bib17 article-title: Intratumor heterogeneity: evolution through space and time publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-2217 – volume: 346 start-page: 256 year: 2014 ident: 2022061704582044300_bib5 article-title: Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing publication-title: Science doi: 10.1126/science.1256930 – volume: 34 start-page: 5309 year: 2015 ident: 2022061704582044300_bib8 article-title: The origin of breast tumor heterogeneity publication-title: Oncogene doi: 10.1038/onc.2014.475 – volume: 75 start-page: 4429 year: 2015 ident: 2022061704582044300_bib15 article-title: Mitochondrial genetics regulate breast cancer tumorigenicity and metastatic potential publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-0074 – volume: 11 start-page: 450 year: 2011 ident: 2022061704582044300_bib13 article-title: Human cancers express mutator phenotypes: origin, consequences and targeting publication-title: Nat Rev Cancer doi: 10.1038/nrc3063 – volume: 344 start-page: 1396 year: 2014 ident: 2022061704582044300_bib4 article-title: Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma publication-title: Science doi: 10.1126/science.1254257 – volume: 32 start-page: 353 year: 2013 ident: 2022061704582044300_bib12 article-title: Do mutator mutations fuel tumorigenesis? publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-013-9426-8 – volume: 12 start-page: 144 year: 2012 ident: 2022061704582044300_bib16 article-title: Mouse models of cancer: does the strain matter? publication-title: Nat Rev Cancer doi: 10.1038/nrc3206 – volume: 2 start-page: 727 year: 2002 ident: 2022061704582044300_bib23 article-title: Clinical translation of angiogenesis inhibitors publication-title: Nat Rev Cancer doi: 10.1038/nrc905 – volume: 68 start-page: 3551 year: 2008 ident: 2022061704582044300_bib14 article-title: Cancers exhibit a mutator phenotype: clinical implications publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-5835 – volume: 3 start-page: 151 year: 1985 ident: 2022061704582044300_bib2 article-title: Implications of tumor progression on clinical oncology publication-title: Clin Exp Metastasis doi: 10.1007/BF01786761 – volume: 84 start-page: 1280 year: 2001 ident: 2022061704582044300_bib21 article-title: Relationship of hypoxia to metastatic ability in rodent tumours publication-title: Br J Cancer doi: 10.1054/bjoc.2001.1743 – volume: 14 start-page: 430 year: 2014 ident: 2022061704582044300_bib22 article-title: Hypoxia and the extracellular matrix: drivers of tumour metastasis publication-title: Nat Rev Cancer doi: 10.1038/nrc3726 – volume: 48 start-page: 6109 year: 1988 ident: 2022061704582044300_bib19 article-title: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations publication-title: Cancer Res – volume: 44 start-page: 2259 year: 1984 ident: 2022061704582044300_bib1 article-title: Tumor heterogeneity publication-title: Cancer Res – start-page: 279 year: 1989 ident: 2022061704582044300_bib3 article-title: Factors involved in the development and maintenance of tumor heterogeneity – volume: 45 start-page: 968 year: 1990 ident: 2022061704582044300_bib18 article-title: The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice publication-title: Int J Cancer doi: 10.1002/ijc.2910450532 – volume: 26 start-page: 19 year: 2009 ident: 2022061704582044300_bib20 article-title: The tumor microenvironment and metastatic disease publication-title: Clin Exp Metastasis doi: 10.1007/s10585-008-9182-2 – volume: 518 start-page: 422 year: 2015 ident: 2022061704582044300_bib24 article-title: Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution publication-title: Nature doi: 10.1038/nature13952 – reference: 18483233 - Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557 – reference: 3902300 - Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88 – reference: 11336482 - Br J Cancer. 2001 May 4;84(9):1280-5 – reference: 18543068 - Clin Exp Metastasis. 2009;26(1):19-34 – reference: 21593786 - Nat Rev Cancer. 2011 Jun;11(6):450-7 – reference: 23002210 - Cancer Res. 2012 Oct 1;72(19):4875-82 – reference: 25301631 - Science. 2014 Oct 10;346(6206):256-9 – reference: 22439924 - Cancer Cell. 2012 Mar 20;21(3):283-96 – reference: 23592419 - Cancer Metastasis Rev. 2013 Dec;32(3-4):353-61 – reference: 22257951 - Nat Rev Cancer. 2012 Feb;12(2):144-9 – reference: 26471915 - Cancer Res. 2015 Oct 15;75(20):4429-36 – reference: 2159442 - Int J Cancer. 1990 May 15;45(5):968-71 – reference: 3167857 - Cancer Res. 1988 Nov 1;48(21):6109-14 – reference: 25470049 - Nature. 2015 Feb 19;518(7539):422-6 – reference: 24827502 - Nat Rev Cancer. 2014 Jun;14(6):430-9 – reference: 24048069 - Nature. 2013 Sep 19;501(7467):365-72 – reference: 24925914 - Science. 2014 Jun 20;344(6190):1396-401 – reference: 6372991 - Cancer Res. 1984 Jun;44(6):2259-65 – reference: 25703331 - Oncogene. 2015 Oct 16;34(42):5309-16 – reference: 23640024 - Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48 – reference: 24048065 - Nature. 2013 Sep 19;501(7467):328-37 – reference: 23345162 - Cancer Res. 2013 Feb 1;73(3):1037-45 – reference: 12360276 - Nat Rev Cancer. 2002 Oct;2(10):727-39 |
SSID | ssj0005105 |
Score | 2.4737954 |
SecondaryResourceType | review_article |
Snippet | Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different... Heterogeneity is commonplace in all cancer types and at several levels--intrinsic (genetic), epigenetic, positional, and at the population level. The different... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 4 |
SubjectTerms | Genetic Heterogeneity Humans Neoplasms - genetics Neoplasms - pathology Tumor Microenvironment |
Title | Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26729788 https://www.proquest.com/docview/1754093470 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDddHjISt5VDHuPEPlYFtAtiT7tib1HsOOLQTVZ9XDj1R3BY_l5_CePYaVJUHsslitxm3GY-z8MzniHkTWUbWKuUs1RWggHokimIFC53KKOiNCHoNkH2ND0-h48X_GI0uhpkLa2WKtDf9p4r-R-u4hjy1Z6SvQFnt0RxAO-Rv3hFDuP133i8umzmqDnw3TT4JWMr_PvkBZgcdbdipwLV1J1T7D6UrrESmp0Ig0HNkJN6Yd32hT9NYMM5_dZeX9lAm_mRrxf0tQ0Iu8yOVvLMZsFgn-GLmbmuU4izGg3_YLjfEA33GzoZKhgH13AnML3YzMAVhuzkquvrsoMfJyRhoG3T_WKcC5f36GYKppNTFnGWhDH0equL1f-izrZJhq17w4UNr4vcksmRTB7x3JK5RW7H6FhYUf7u5FOfFOSTXruZ_ZkvJPN276_ZtWZ-46K0psrZfXLP-xh04gDzgIxM_ZDc-eyzKB6RosUN3cHNZv19Qjfr6yFWqMfKZv2DepTQpqY9SmiHEooooQOUPCbnH96fTY-Zb7XBNMTxktk2BTpE29DwLCoTqdCMr9D4TbMyQRc6TJLU1rGMSsFVqMpYKalVpG1poSrFweQJOaib2jwjFHWAwgWeVgYKKGzLHRmHhYQMbVuplBkT6F5Zrn0detsOZZb_kWFjEmwfu3KFWP72wOuOHzmKTBsHK2rTrBY5WswQygSycEyeOkZtSeI_jmUmxOFNp3tO7var5QU5WM5X5iXaq0v1qoXYTx1Uiqk |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+Heterogeneity%E2%80%94A+%E2%80%98Contemporary+Concept%E2%80%99+Founded+on+Historical+Insights+and+Predictions&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Welch%2C+Danny+R.&rft.date=2016-01-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=76&rft.issue=1&rft.spage=4&rft.epage=6&rft_id=info:doi/10.1158%2F0008-5472.CAN-15-3024&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_0008_5472_CAN_15_3024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |